Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference
What's included
Standard protocols for foot-related tendon issues typically involve 0.25-0.5 mg daily via subcutaneous injection near the affected area for 4-8 weeks
Koniver attributed these lapses to charting issues and said that no patients were harmed
US$ 25.58
US$ 29.77
US$ 26.87
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 20.28
